Literature DB >> 19819514

Pseudorabies virus US3- and UL49.5-dependent and -independent downregulation of MHC I cell surface expression in different cell types.

Matthias J Deruelle1, Céline Van den Broeke, Hans J Nauwynck, Thomas C Mettenleiter, Herman W Favoreel.   

Abstract

Many herpesviruses interfere with the MHC I antigen-processing pathway in order to limit elimination by cytotoxic T-lymphocytes. For varicelloviruses, the largest subgroup of alphaherpesviruses, two viral proteins have been reported to downregulate MHC I cell surface expression: UL49.5 for BoHV-1, PRV, and EHV-1 and the US3 orthologue for VZV. Here, we report that PRV reduces MHC I cell surface expression during infection in a cell-type-dependent manner. In ST cells, a kinase-active US3 was necessary but not sufficient to downregulate cell surface MHC I expression, whereas US3 was not required in PK-15 cells and porcine alveolar macrophages (PAM). MHC I downregulation was not (PAM, ST) or only partly (PK-15) dependent on UL49.5. In conclusion, we show that the mechanism(s) of PRV-mediated cell surface MHC I downregulation are cell-type-dependent, with variable roles for US3, UL49.5, and additional, yet unidentified early viral proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819514     DOI: 10.1016/j.virol.2009.09.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

2.  Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I.

Authors:  Guanggang Ma; Silke Feineis; Nikolaus Osterrieder; Gerlinde R Van de Walle
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  The IE180 protein of pseudorabies virus suppresses phosphorylation of translation initiation factor eIF2α.

Authors:  N Van Opdenbosch; C Van den Broeke; N De Regge; E Tabarés; H W Favoreel
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.

Authors:  Abdelrahman Said; Walid Azab; Armando Damiani; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  Equine Herpesvirus 1 Multiply Inserted Transmembrane Protein pUL43 Cooperates with pUL56 in Downregulation of Cell Surface Major Histocompatibility Complex Class I.

Authors:  Teng Huang; Guanggang Ma; Nikolaus Osterrieder
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

6.  The alphaherpesvirus serine/threonine kinase us3 disrupts promyelocytic leukemia protein nuclear bodies.

Authors:  Masany Jung; Renée L Finnen; Casey E Neron; Bruce W Banfield
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

7.  Herpes simplex virus 1 gN partners with gM to modulate the viral fusion machinery.

Authors:  Imane El Kasmi; Roger Lippé
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

8.  Immune regulation and evasion of Mammalian host cell immunity during viral infection.

Authors:  B M Pratheek; Soham Saha; Prasanta K Maiti; Soma Chattopadhyay; Subhasis Chattopadhyay
Journal:  Indian J Virol       Date:  2013-03-15

9.  Us3 kinase encoded by herpes simplex virus 1 mediates downregulation of cell surface major histocompatibility complex class I and evasion of CD8+ T cells.

Authors:  Takahiko Imai; Naoto Koyanagi; Ryo Ogawa; Keiko Shindo; Tadahiro Suenaga; Ayuko Sato; Jun Arii; Akihisa Kato; Hiroshi Kiyono; Hisashi Arase; Yasushi Kawaguchi
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

10.  Comparison of Pathogenicity-Related Genes in the Current Pseudorabies Virus Outbreak in China.

Authors:  Yan-Dong Tang; Ji-Ting Liu; Tong-Yun Wang; Ming-Xia Sun; Zhi-Jun Tian; Xue-Hui Cai
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.